Currently out of the existing stock ratings of Allison Bratzel, 60 are a BUY (86.96%), 9 are a HOLD (13.04%).

Allison Bratzel

Work Performance Price Targets & Ratings Chart

Analyst Allison Bratzel, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 63% that have a potential upside of 71.28% achieved within 294 days.

Allison Bratzel’s has documented 133 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 16-Aug-2026.

Wall Street Analyst Allison Bratzel

Analyst best performing recommendations are on RIGL (RIGEL PHARMACEUTICALS).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 11/14/2024. The price target of $23 was fulfilled within 4 days with a profit of $4.46 (16.24%) receiving and performance score of 40.6.

Average potential price target upside

of $88.23 (21.45%) on ARGX (ARGENX NV ADR).
of $17.98 (27.43%) on INCY (YTE).
of $16.56 (145.98%) on SRRK (SCHOLAR ROCK HOLDING CORP).

ARGX argenx NV ADR ENGN enGene Holdings Common Stock HUMA Humacyte INCY yte IONS Ionis Pharmaceuticals MGTX MeiraGTx Holdings PLC REPL Replimune Group RIGL Rigel Pharmaceuticals ROIV Roivant Sciences Ltd SRRK Scholar Rock Holding Corp TVTX Travere Therapeutics TYRA Tyra Biosciences AKBA Akebia Ther

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

David Nierengarten (WEDBUSH)